31-Aug-2009 | research and development
Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin for Treatment of Type 2 Diabetes
Takeda Pharmaceutical Company Limited and Takeda Global Research & Development Center, Inc., a wholly owned United States subsidiary, jointly announced ...